Long-term therapy with enalapril in patients with nephrotic-range proteinuria

Pediatric Nephrology

Volumn 10, Issue 5, 1996, Pages 587-589

  Proesmans, Willem ^a   Van Wambeke, Inge ^a   Van Dyck, Maria ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Enalapril; Idiopathic steroid resistant nephrotic syndrome

Indexed keywords

CHLORAMBUCIL; CYCLOSPORIN A; DIPYRIDAMOLE; ENALAPRIL; STEROID;

ADOLESCENT; ALPORT SYNDROME; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; NEPHROSIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; SCHOOL CHILD;

ADOLESCENT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; CHILD; CREATININE; ENALAPRIL; GLOMERULAR FILTRATION RATE; HUMANS; PROTEINURIA; SERUM ALBUMIN;

EID: 0029783422     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004670050166     Document Type: Article

References (12)

1. Anderson S, Brenner BM (1987) Therapeutic implications of converting-enzyme inhibitors in renal disease. Am J Kidney Dis 10: 81-87
2. Anderson S, Rennke H, Brenner BM (1986) Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77: 1993-2000
3. Terzi F, Beaufils H, Laouari D, Burtin M, Kleinknecht C (1992) Renal effect of antihypertensive drugs dependent on sodium diet in the excision remnant kidney model. Kidney Int 42: 354-363
4. Trachtman H, Del Pizzo R, Valderrama E, Gauthier B (1990) The renal functional and structural consequences of corticosteroid and angiotensin-converting enzyme inhibitor therapy in chronic puromycin aminonucleoside nephropathy. Pediatr Nephrol 4:501-504
5. Brouhard BH, Takamori H, Satoh S, Inman S, Cressman M, Irwin K, Verkley V, Stowe N (1994) The combination of lovastatin and enalapril in a model of progressive renal disease. Pediatr Nephrol 8: 436-440
6. Heeg JE, De Jong PE, Van der Hem GK, De Zeeuw D (1987) Reduction of proteinuria by angiotensin converting enzyme inhibition. Kidney Int 32: 78-83
7. Praga M, Hernandez E, Montoyo C, Andres A, Ruilope L, Rodicio J (1992) Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria. Am J Kidney Dis 20: 240-248
8. Zuchelli P, Zuccala A, Borghi M, Fusaroli M, Sasdelli M, Stallone C, Sanna G, Gaggi R (1992) Long-term comparison between captopril and nifedipine in the progression of renal insufficiency. Kidney Int 42: 452-458
9. Gansevoort RT, De Zeeuw D, De Jong PE (1993) Long-term benefits of the antiproteinuric effect of angiotensin-converting enzyme inhibition in nondiabetic renal disease. Am J Kidney Dis 22: 202-206
10. Trachtman H, Gauthier B (1988) Effect of angiotensin-convernting enzyme inhibitor therapy on proteinuria in children with renal disease. J Pediatr 112: 295-298
11. Millner DS, Morgenstern BZ (1991) Angiotensin converting enzyme inhibitors for reduction of proteinuria in children with steroid-resistant nephrotic syndrome. Pediatr Nephrol 5: 587-590
12. Ueda N, Kawaguchi S, Niinomi Y, Nonoda T, Ohnishi M, Ito S, Yasaki T (1986) Effect of dipyridamole treatment on proteinuria in pediatric renal disease. Nephron 44: 174-179